FilingReader Intelligence
Huahai Pharmaceutical delays major project, releases surplus funds
July 24, 2025 at 05:17 PM UTC•By FilingReader AI
Zhejiang Huahai Pharmaceutical extended its "Pharmaceutical Digital Intelligent Manufacturing Project" to December 2026 from July 2025, citing investment scale and preparation requirements. The 420 million yuan project has utilized 237.57 million yuan by June 2025.
The company released 9.63 million yuan in surplus funds from a completed biotechnology project to supplement working capital.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Verification opinion of Zheshang Securities Company Limited on the extension of certain fundraising investment projects of Zhejiang Huahai Pharmaceutical Company LimitedJuly 24, 2025 at 08:00 AM UTC
Announcement by Zhejiang Huahai Pharmaceutical Co., Ltd. regarding the completion of fundraising projects and the permanent replenishment of working capital with the remaining raised fundsJuly 24, 2025 at 08:00 AM UTC
Announcement on the resolutions of the second extraordinary meeting of the ninth board of directors of Zhejiang Huahai Pharmaceutical Company LimitedJuly 24, 2025 at 08:00 AM UTC
Resolution of the first 2025 special meeting of independent directors of the ninth board of directors of Zhejiang Huahai Pharmaceutical Company LimitedJuly 24, 2025 at 08:00 AM UTC
News Alerts
Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news
Free account required • Unsubscribe anytime